Anti d dosage for pregnant women at 12 weeks
Reading File
Finding Sources
Finding Sources
Searching PubMed
"anti-D immunoglobulin" AND "first trimester" AND dosage
Reading File
Reading File
Reading File
Reading Article
I now have comprehensive information. Here is the full answer:
Anti-D Immunoglobulin (RhIG) Dosage at 12 Weeks of Pregnancy
Who Needs It
Anti-D (Rh immune globulin / RhoGAM) is given to RhD-negative pregnant women who are exposed to a potential fetomaternal hemorrhage event, to prevent Rh alloimmunization and subsequent hemolytic disease of the fetus and newborn (HDFN).
Dose at 12 Weeks
12 weeks sits right at the cutoff point between the "mini-dose" and "full-dose" regimens:
| Gestational Age | Recommended Anti-D Dose |
|---|---|
| < 12 weeks | 50 mcg (mini-dose) - sufficient because fetal red cell volume is small |
| = 12 weeks (at or after) | 300 mcg (full dose) - standard full vial |
| > 12 weeks | 300 mcg (full dose) |
At exactly 12 weeks, standard practice is to give the 300 mcg full dose, as the threshold is "less than 12 weeks" for the mini-dose.
Practical note: Many pharmacies and hospitals only stock the 300 mcg (full dose) vial. The 300 mcg dose is always acceptable even before 12 weeks - it is not harmful to give the higher dose at any gestational age.
- Rosen's Emergency Medicine, p. 3359
- Quick Compendium of Clinical Pathology, 5th ed., t2.27
Indications at 12 Weeks (When to Give It)
Anti-D should be given within 72 hours of any of the following sensitizing events at or around 12 weeks:
- Threatened miscarriage / vaginal bleeding
- Spontaneous or induced abortion
- Ectopic pregnancy (especially surgery)
- Chorionic villus sampling (CVS)
- Amniocentesis
- Uterine trauma or manipulation
- Any other event with possible fetomaternal hemorrhage
Routine antenatal prophylaxis is given separately at 28 weeks (300 mcg) and again at delivery - not typically at 12 weeks unless a sensitizing event occurs.
Calculating Dose After Significant Hemorrhage (> 12 Weeks)
If a large fetomaternal hemorrhage is suspected (e.g., trauma), a Kleihauer-Betke (KB) test is done to quantify fetal cells in maternal blood, and additional vials may be needed:
Dose (vials) = (Maternal blood volume in mL x proportion of fetal cells) / 30
- Each 300 mcg vial protects against 30 mL whole blood (15 mL RBCs)
- Always round up and add 1 vial
- Maximum 5 vials IM at one time; larger doses may be given IV
- Quick Compendium of Clinical Pathology, 5th ed., t2.28
Important 2026 Update
A recent systematic review (Gemzell-Danielsson et al., Int J Gynaecol Obstet, 2026 - PMID 40728267) found that WHO guidelines from 2022 onwards recommend against routine anti-D prophylaxis for first-trimester abortion, noting insufficient evidence of significant sensitization risk before 12 weeks of amenorrhea. However, most traditional/older guidelines still recommend it. This remains an area of evolving guidance, and clinicians should apply shared decision-making and follow their institutional protocols.
Quick Summary
| Parameter | Value |
|---|---|
| Dose at 12 weeks | 300 mcg (full dose) |
| Route | IM (intramuscular) |
| Timing | Within 72 hours of sensitizing event |
| Half-life | ~24 days |
| Protects against | Up to 15 mL fetal RBCs (30 mL whole blood) per vial |
This is a shared conversation. Sign in to Orris to start your own chat.